Apptomics

Apptomics was a digital health company that specialized in developing mobile applications for the objective monitoring of neurological disorders, particularly Parkinson's disease. Its primary product, iMove, utilized smartphone-embedded sensors to track motor symptoms such as tremors and gait in a patient's natural environment. The company aimed to provide clinicians and researchers with continuous, real-world data to supplement traditional clinical assessments. Founded by experts from the University of Rochester, Apptomics played a significant role in the early adoption of digital biomarkers in neurology. Although the company is no longer active, its technologies contributed to the advancement of remote patient monitoring in chronic disease management.